Delivery Order SPE2DB22D2206-SPE2DB25FJM88
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $18,837.70 delivery order on August 19, 2025, for the supply of Remicade 100 mg vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,603.96 on July 29, 2025, for the supply of Remicade 100 mg vials, with a completion date of July 30, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $23,484.87 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 12, 2025. This firm fixed price contract, awarded on August 11, 2025, represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,774.78 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling through December 2026. The delivery order was executed on August 4, 2025, with an ultimate completion date of August 5,...
- The Defense Logistics Agency awarded a delivery order valued at $2,366.24 to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for $5,012.20 to supply 100 mg vials of Remicade, a biologic immunosuppressant medication used to treat autoimmune conditions. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 6, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $6,250.50 firm fixed price delivery order contract to supply 4561696173 units of Remicade 100 mg vials. The single day contract has a period of performance from August 3 to August 4, 2023, with all work taking place in Conshohocken, Pennsylvania. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. Department of Defense, this delivery order was likely placed to...
- The Defense Logistics Agency awarded a $3,532 delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of the drug Remicade. The firm fixed price order is for performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania from August 14 to August 15, 2023. As a major pharmaceutical distributor, Amerisourcebergen supports the DLA's medical supply chain requirements through its Prime Vendor Next contract vehicle. No subcontractors or set aside designations were identified...
- The Defense Logistics Agency Troop Support Medical awarded a $12,180 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 mg vials of Remicade. The place of performance is Conshohocken, Pennsylvania, with performance period spanning August 31, 2023 through September 1, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the rheumatoid arthritis treatment Remicade supports the Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $12,826 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg vials of Remicade. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order runs from June 29, 2023 through June 30, 2023. Remicade is a biologic medication used to treat certain autoimmune disorders. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle held by...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJM88Delivery Order
The Defense Logistics Agency awarded a $50,458.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Remicade 100 mg vials, with an ultimate completion date of August 21, 2025. This is a non-set-aside competitive award issued on August 20, 2025, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026, which serves as the prime contract for comprehensive pharmaceutical support to military healthcare programs globally. Remicade is a biologic immunosuppressant medication primarily used for treating rheumatoid arthritis, inflammatory bowel disease, and other autoimmune conditions. This delivery order represents a routine pharmaceutical supply transaction supporting the Defense Health Agency's medical supply chain requirements. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability to deliver specialized pharmaceutical products to military and federal healthcare systems on a competitive basis. The award aligns with DLA's ongoing pharmaceutical supply operations and supports continued medical readiness across the Department of Defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 8/20/25 |